A study presented at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute ...

A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) face a 2.7-fold higher risk of death ...

The drug has demonstrated clinical benefit in slowing lung function decline in IPF and is now being evaluated for oncology-related pulmonary complications. Gyre has held first-in-class status for ...

The drug has demonstrated clinical benefit in slowing lung function decline in IPF and is now being evaluated for oncology-related pulmonary complications. Gyre has held first-in-class status for ...

In addition to COPD, Dupixent is approved in Japan in certain patients with atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), prurigo nodularis and chronic ...

The usual Perforomist dosage for COPD is one treatment with a nebulizer twice per day. Specific dosages may vary depending on factors such as other medications you may be taking. It’s important ...

If acidosis puts too much pressure on these organs, it can cause serious complications. Certain health conditions, prescription drugs, and dietary factors can cause acidosis. Some cases of ...

Over time, these smaller vessels can swell under the added load, eventually leading to various complications [1]. Portal hypertension can be caused by various factors, including liver disease ...

The new study sheds light on the underlying mechanisms of pulmonary fibrotic diseases and identifies potential new targets and options for therapy to improve patients' outcomes. Researchers have ...